Biotech

All Articles

Innovent hyperlinks cytokine to colorectal cancer cells reactions

.Innovent Biologics has produced the instance that its own gate inhibitor-cytokine fusion healthy pr...

Merck, Daiichi ADC strikes goal in phase 3 lung cancer cells research

.A stage 3 trial of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) ...

Rakovina grows artificial intelligence center with collab to pick cancer aim ats

.Five months after Rakovina Rehabs rotated towards artificial intelligence, the cancer-focused biote...

Ascendis' dwarfism medicine favorites in period 3, intimidates BioMarin

.Ascendis Pharma has emerged as a potential threat to BioMarin's Voxzogo, stating phase 3 developmen...

Despite ph. 3 miss, Alkeus sees road in advance for eye health condition asset

.Though Alkeus Pharmaceuticals' dental eye condition resource neglected to significantly lessen geog...

Kairos goes social with $6M IPO to fund trials of cancer cells medication

.Along with a triad of biotechs striking the Nasdaq on Friday, it was actually very easy to overlook...

Vaccine and Keytruda combination efficient in squamous tissue cancer

.Immune gate inhibitors are actually the superheroes of cancer cells treatment. Drugs like Bristol M...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of notable management hirings, shootings and re...

Regeneron's Opdualag rival reveals 57% feedback price

.Regeneron is actually back along with lasting follow-up for its LAG-3 prevention and PD-1 inhibitor...

AstraZeneca posts records on in-house rivals to AbbVie, Pfizer ADCs

.AstraZeneca has actually discussed an early take a look at the functionality of its own in-house an...